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ABSTRACT
Objectives: Gradual age-related cognitive
deteriorations are common and are hypothesised to be
partially attributable to declines in information-
processing speed. The Iowa Healthy and Active Minds
Study will evaluate the efﬁcacy and effectiveness of
a computerised visual processing speed training
programme (Road Tour, Posit Science Corporation,
San Francisco, California).
Methods and analysis: Using a 3:3:4:4 ratio within
two age strata (50e64 vs $65 years old), 681 men
and women attending family care clinics were
randomised to four treatment groups: 10 h of on-site
Road Tour training, 10 h of on-site Road Tour training
with 4 h of booster training at 11 months
postrandomisation, 10 h of on-site attention control
using computerised crossword puzzles (Boatload of
Crosswords, Boatload Puzzles, LLC, Yorktown Heights,
New York) and 10 h of at-home Road Tour training
using the participant’s personal computer. The primary
outcome, visual processing speed, was assessed at
randomisation and post-training (6e8 weeks
postrandomisation), and is being reassessed at 1-year
postrandomisation using the Useful Field of View test.
Five secondary outcomes (Symbol Digit Modalities
Test, Trail Making Tests A and B, Controlled Oral Word
Association Test, Digit Vigilance Test, and the Stroop
Colour and Word Test) were assessed at
randomisation and will be reassessed at 1-year
postrandomisation. Seven hypotheses will be tested
using intent-to-treat analyses involving multiple linear,
logistic, Poisson and negative binomial regression.
Ethics and dissemination: Ethics approval was
provided by the University of Iowa Institutional Review
Board (IRB-03 protocol 200908789). All participants
completed signed informed consent prior to
enrolment. Road Tour is commercially available from
Posit Science Corporation, which provided it to Iowa
Healthy and Active Minds Study at no cost. All
participants will receive a free copy of Road Tour for
unlimited perpetual use at study completion.
Clinical Trial Registration
Number: NCT01165463.
INTRODUCTION
Some degree of gradual, age-related cogni-
tive decline is recognised as universal and as
a normal part of the ageing process. This
decline is evident across several domains
including memory, orientation, attention,
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ARTICLE SUMMARY
Article focus
- Given that age-related declines in cognitive
functioning are part of the normal ageing
process, there is a pressing need for efﬁcient
and effective training interventions that improve
cognitive functioning in older adults.
- This protocol paper outlines the design of a study
that overcomes several important limitations of
a prior, large, multisite randomised controlled
trial (RCT) that used memory, reasoning and
speed of processing interventions, but found that
only the latter effectively translated to improved
health outcomes.
- This RCT evaluates the efﬁcacy and effectiveness
of a second-generation computerised visual speed-
of-processing intervention using three modes of
delivery (on-site without booster training, on-site
with booster training and at-home use) versus an
attention control (on-site computerised crossword
puzzles without booster training) in improving
cognitive processing speed and health outcomes.
Key messages
- This is an RCT protocol.
- Iowa Healthy and Active Minds Study is the ﬁrst
RCT to evaluate the efﬁcacy and effectiveness of
a commercially available computerised visual speed
of processing intervention known as Road Tour.
- If this intervention is successful, the product
vendor pledges to make the computerised
intervention software available to governments
for widespread distribution and use at a fraction
of the current commercial cost.
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Open Access Protocolabstract thinking and perception.
1e4 Age-related cogni-
tive changes can best be viewed as one end of
a continuum that includes preclinical disease, mild
cognitive impairment and dementia.
5e8
As the brain and the visual system age, many changes
occur from the periphery through the central nervous
system, contributing to deﬁcits in visual perception and
cognition.
9e11 Deﬁcits are particularly notable in visual
tasks requiring high levels of temporal precision (visual
speed of processing) and attention (tracking multiple
objects). These deﬁcits are signiﬁcant contributors to
declines that emerge in visual cognition and visually
guided basic and instrumental activities of daily living
(ADLs and IADLs),
12 13 and can be understood as the
consequence of central nervous system changes
involving brain plasticity. These brain-plasticity-driven
changes are likely important contributors to the speed,
memory and cognitive deﬁcits common in normal
ageing.
14 15 Brain plasticity, however, also creates an
opportunity to strengthen cognitive abilities, and many
studies have investigated the effects of interventions
targeting speciﬁc abilities such as memory, attention
control, spatial orientation, inductive reasoning, ﬁgural
relations and artistic expression, or more globally by
targeting multiple domains.
A new generation of these intervention studies is quite
promising. Especially encouraging are recent studies
that provide ‘.structured experience in situations
demanding executive coordination of skillsdsuch as
complex video games, task-switching paradigms and
divided attention tasks.’
14 (p. 1). The advantage of
these studies is that they ‘train strategic control over
cognition that does transfer to different environments’
14
(p. 1). Several such studies focus on improving visual
processing speed.
16e19
Salthouse has hypothesised that declines in processing
speed adversely affect cognition in two waysdthe limited
time and simultaneity mechanisms.
20 Limited time refers
to the restriction in the amount of time available to
successfully accomplish a task when certain cognitive
processes are completed too slowly. Simultaneity oper-
ates when slowed information processing promotes the
loss of early cognitive processing products through decay
or displacement before they are needed for later oper-
ations. Extensive evidence supports the speed of
processing theory of age-related cognitive decline.
19e23
Associations between various subjective and objective
health-status measures and cognitive functioning are
also related to processing speed to a greater degree than
to other higher-order cognitive processes, suggesting an
important link between speed of processing and health
outcomes.
24 Moreover, Salthouse has shown that
processing speed peaks at about age 23, plateaus until
age 28 and then declines in a linear fashion throughout
the remainder of the life course.
25
One of the most promising interventions focused on
improving visual processing speed was developed by Ball
and Roenker.
19 20 26 It improves the efﬁciency and
accuracy of visual information processing and the ability
to perform complex visual attention tasks. Speciﬁcally,
users are trained to improve the speed and accuracy with
which they identify and locate visual information using
a divided attention format. Over time, the difﬁculty and
complexity of each task are systematically increased as
users attain speciﬁed performance criteria. Manipula-
tions to increase difﬁculty include decreasing the dura-
tion for which visual stimuli are presented, adding visual
or auditory distracters, increasing similarity between
target and distracter stimuli, and presenting visual
targets over a broader spatial expanse. The basic tasks,
however, are always the samedcentral discrimination
and peripheral target location.
Ball and Roenker’s
19 20 26 programme was extensively
evaluated in the Advanced Cognitive Training for Inde-
pendent and Vital Elderly (ACTIVE) trial.
27 ACTIVE
hypothesised that each of three intervention arms
(memory, reasoning and visual processing speed
training) would have a direct effect on targeted, trained
outcomes (proximal outcomes) and non-speciﬁc effects
on its non-targeted, untrained outcomes (via social
contact or cognitive engagement mechanisms). The
reasoning and memory interventions were expected to
affect only everyday problem solving and ADLs and
IADLs, whereas the speed of processing intervention was
hypothesised to have more diverse effects, including
ADL and IADL functioning, everyday speed and driving
habits. All three interventions were expected to affect
the secondary outcomes, including health-related quality
of life (HRQoL), depressive symptoms and locus of
control. Although all ACTIVE treatments were effective
at improving their targeted abilities, visual speed of
processing led to the largest gains.
28 29 Moreover, the
greatest relative improvements were clearly associated
with visual speed of processing training as well, which
produced effect sizes more than double those associated
with the two other interventions at every time point.
The effects of ACTIVE’s visual speed of processing
intervention (vs the no-contact control group) on the
secondary or health outcomes have been shown as well.
These included: (1) a $244 per person-year (3%)
reduction (p¼0.012) in predicted medical expenses at
ARTICLE SUMMARY
Strengths and limitations of this study
- This study uses six well-established, objective neuropsycho-
logical assessments of cognitive processing speed, as well as
three highly reliable and valid self-reported measures of health
outcomes in a large sample of men and women 50 years old
and older.
- Although the sample is large, it was drawn from just one large
primary care centre in which minorities are under-represented
and the key assessments are only conducted at randomisation,
after initial training (6-8 weeks postrandomisation) and at 1-
year postrandomisation, thereby reducing the opportunity to
demonstrate the long-term effects of the intervention.
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30; (2) a 38% reduction in the risk of global decline
in HRQoL at 2 years (p¼0.004) and a 25.6% reduction
in the risk of global decline in HRQoL (p¼0.038) at
5 years
31 32; (3) a 30% reduction in the risk of worsening
depressive symptoms at both 1 year (p¼0.012) and
5 years (p¼0.023)
33; (4) a 38% reduction in the risk of
the onset of suspected clinical depression at 1 year
(p<0.01)
34; (5) improvements in self-rated health at 2, 3
and 5 years equivalent to at least half of the difference
between ‘excellent’ and ‘very good’ responses (p<0.05),
which is known to be associated with a 0.8% absolute
reduction in the 5-year mortality, and a 10% relative
mortality reduction
35; and (6) a 64% greater likelihood
(p<0.05) of improvements in internal locus of control at
5 years.
36 No adverse effects of speed of processing
training in ACTIVE have been identiﬁed.
As important as it was, however, ACTIVE had ﬁve
serious limitations. First, ACTIVE used a no-contact
rather than an attention control group, making it
impossible to rule out placebo effects. Second, ACTIVE’s
approach to booster training was compliance-condi-
tioned, making it impossible to separate adherence
effects from dosing levels. Third, ACTIVE relied on only
one speed of processing assessment test (the Useful
Field of View, or UFOV
37), which was sufﬁciently
thematically and procedurally comparable with the
speed of processing intervention itself that the results
could merely reﬂect ‘training to the test.’ Fourth,
ACTIVE used an early version of the speed of processing
training that required supervised assistance, and is thus
not practical for widespread implementation. Finally,
ACTIVE included only participants $65 and thus cannot
be used to address the important issue of whether earlier
age-related declines
25 can be avoided or ameliorated.
CURRENT STUDY
We designed the Iowa Healthy and Active Minds Study
(IHAMS) to overcome ACTIVE’s ﬁve limitations. IHAMS
is a four-group RCT (NCT01165463). The ﬁrst group
received a standard dose (10 h) of computerised visual
processing speed training in our laboratory. The second
group also received a standard dose of computerised
visual-processing speed training in our laboratory, but
they were invited back to the laboratory for 4 h of
subsequent booster training regardless of their adher-
ence to their training. The third group (attention
control) received a standard dose of training using
computerised crossword puzzles in our laboratory. The
ﬁnal group took the computerised visual processing
speed training software home to use it on their personal
computer (PC) for at least a standard dose. The primary
outcome is visual processing speed, which was assessed at
randomisation and after the completion of training (at
6e8 weeks postrandomisation), and will be assessed
again at 1-year postrandomisation. Five secondary
cognitive processing speed outcomes were assessed at
randomisation and will be assessed again at 1 year
thereafter.
We speciﬁed seven a priori hypotheses (Hn) that we
expect to be supported by separate analyses in each age
stratum. The ﬁrst addresses changes in the primary
outcome between randomisation and post-testing.
Because no standard booster training occurred by this
time, and because supplemental training beyond 10 h in
the at-home group should have been minimal, we
hypothesise (H1) that participants randomised to Road
Tour training (Groups 1, 2 and 4) should have signiﬁ-
cantly and similarly greater improvements in visual
processing speed immediately after training than the
attention control group (Group 3).
The six remaining hypotheses address expectations
about changes in all six of the primary and secondary
outcomes between randomisation and 1-year post-
randomisation. H2 replicates ACTIVE (ie, on-site
delivery) and hypothesises that the basic and booster
effects of visual speed of processing (Group 2) will be
signiﬁcantly greater than those observed for the atten-
tion control group (Group 3). To separate the basic
effect (Group 1) from the basic plus booster effect
(Group 2), we further hypothesise (H3) that Group 1
will also improve signiﬁcantly more than Group 3
(attention control), but that (H4) Group 2 will improve
signiﬁcantly more than Group 1. H5 examines the effect
of the at-home delivery of the visual speed of processing
training (Group 4) versus the effect of the attention
control training (Group 3); here we expect a signiﬁ-
cantly greater improvement for Group 4 than Group 3.
H6 and H7 evaluate the different modes of imple-
menting the visual speed-of-processing intervention. We
hypothesise (H6) that given the potential for individual
dosing and maintenance in Group 4 (at-home training)
it will have a signiﬁcantly greater improvement than
Group 1 (on-site training without boosters). H7 evalu-
ates the potential for individual dosing and maintenance
versus standard booster training; here we hypothesise
that the improvements for Group 4 (unlimited at-home
dosing) will exceed those for Group 2 (in which stan-
dard and booster training doses are ﬁxed).
METHODS AND ANALYSIS
Figure 1 shows the IHAMS study design and participant
recruitment results. IHAMS is a four-arm parallel RCT
using a 3:3:4:4 allocation ratio and block randomisation
separately within two age strata (50e64 and 65e87 years
old). Participants were randomised to one of the
following groups: (1) 10 h (over the ﬁrst 5e6w e e k s )o f
on-site training using Road Tour (Group 1), (2) 10 h of on-
site training using Road Tour plus 4 h of booster training
at 11 months postrandomisation (Group 2), (3) 10 h of
on-site attention control using computerised crossword
puzzles (Group 3) or (4) at-home training using Road
Tour for 10 h or more (Group 4). When enrolment closed
in late November 2010, 681 participants had been rand-
omised with 154 in Group 1, 148 in Group 2, 188 in
Group 3 and 191 in Group 4. Post-training assessments
occurred at 6e8 weeks postrandomisation, and complete
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year postrandomisation assessments are scheduled to be
completed by late November 2011. IHAMS was sized to
provide $80% power to detect an effect size of 0.25 for
H2 at 1-year postrandomisation with a¼0.05.
Study sample and recruitment
The sampling frame included all patients attending
either the general internal or family medicine clinics of
the University of Iowa’s Family Care Center (FCC). The
electronic medical record (Epic, Verona, Wisconsin) was
used to initially select potentially eligible participants
who met the inclusion criteria: (1) $50 years old, (2)
regularly receiving primary care from the FCC ($2 visits
in the past year) and (3) the absence of cognitive
impairment indicated by ICD9-CM codes for Alzheimer’s
disease (331.0), Pick’s disease (331.1), arteriosclerotic
dementia (290.4 to 290.43), other senile or presenile
dementia (290.0 to 290.9), dementia due to alcohol
(291.1 to 291.2) or drugs (292.82 to 292.83), amnestic
syndrome (294.0) or dementia due to other organic
conditions (294.1). A total of 5743 potentially eligible
patients were identiﬁed.
Weekly random (without replacement) replicates of
100e250 of the 5743 potentially eligible patients
received a letter describing the study that was co-signed
by the FCC medical directors (CG and SW) and the
principal investigator (FDW). These patients were asked
to telephone the project ofﬁce to indicate whether they
were or were not interested in participating. A fortnight
later, we initially telephoned non-responders to deter-
mine their interest, but because this approach had a very
low rate of return, it was abandoned.
Telephone screening for eligibility
We attempted to screen all 5743 potentially eligible
patients. Despite $3 telephone calls each, we were
unable to reach 1627. Upon achieving telephone contact
with the remainder, 2079 declined to participate. We
then conducted brief screening interviews among inter-
ested patients. These screening interviews identiﬁed
potential participants who met any of the exclusion
criteria that could not be ascertained using Epic: (1)
signiﬁcant cognitive impairment evidenced by $3 errors
on a 10-item mental status exam,
38 (2) self-reported
uncorrected visual acuity problems that would interfere
with using a PC, (3) not having a PC with a CD-ROM in
the home, (4) not having internet access and (5) having
previously used a cognitive training programme. This led
to the exclusion of 1356 potential participants.
Informed consent and baseline interviews
After successfully completing the screening telephone
interview, eligible patients were scheduled for a 2 h
appointment in our laboratory where the purpose and
design of the study were explained, and written
informed consent was obtained. The informed consent
process took about 15 min. After providing informed
consent, the 681 enrollees were administered their
baseline (randomisation) interviews by trained research
assistants using computer-assisted interviewing proto-
cols. The baseline interviews took about 1.5 h and
included the neuropsychological assessments, health
outcomes and covariates described below. Immediately
after their baseline interview, participants were rando-
mised to one of the four study groups.
Randomisation procedure
The study biostatistician (MPJ) determined the order of
assignments using a computer-generated list of random
numbers and a 3:3:4:4 ratio based on a priori power
calculations. Block randomisation was used to maintain
balance on two age-strata (50e64 and $65). Block sizes
Figure 1 IHAMS CONSORT
ﬂow diagram
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each participant’s ID number was recorded on a partici-
pant letter and then sealed in an opaque envelope with
only the ID number visible. Two age-strata speciﬁc boxes
containing the assignment envelopes were stored in
a locked cabinet in the Project Coordinator’s ofﬁce. The
Project Coordinator (MMD) had the responsibility of
unsealing the envelope (from the appropriate age-
stratum box) and revealing each participant’s group
assignment.
Cognitive processing speed outcomes
The six IHAMS neuropsychological assessments are: (1)
the UFOV PC mouse version
19; (2) the Symbol Digit
Modalities Test (SDMT)
39; (3) the Trail Making A and B
Tests (TMT)
40; (4) the Controlled Oral Word Associa-
tion Test (COWAT)
41; (5) the Digit Vigilance Test
(DVT)
42; and (6) the Stroop Colour and Word Test
(Stroop).
43 The UFOV is the primary outcome and was
administered at randomisation and post-training
(6e8 weeks postbaseline), and will be readministered at
1 year postrandomisation. The UFOV includes three
subtestsdstimulus identiﬁcation, divided attention and
selective attentiondeach scored from 17e500 ms
reﬂecting the shortest exposure time at which the
participant could correctly perform each subtest 75% of
the time, with a composite milliseconds outcome score
ranging from 51e1500 ms.
The SDMT, TMT, COWAT, DVT and Stroop tests are
secondary outcome measures, were all administered at
randomisation and will be readministered at 1 year
postrandomisation. SDMT captures divided attention
and processing speed, and is based on how many of 110
possible digitesymbol pairs were scored as correct pairs
by the participant in 90 s. TMT assesses visual scanning
ability, processing speed and set-shifting/executive
functioning, and is coded as the number of seconds
needed to correctly complete connection of the number
and numbereletter sets. COWAT assesses verbal ﬂuency
based on the number of unique words beginning with
the letter C (or F or L) generated by the participant
during 60 s, with a composite score of the number of
correct words used across the three letter trials. DVT
assesses sustained attention and psychomotor speed, is
performed by crossing out randomly placed 6s in 59 rows
of numbers and is scored as the error and time totals.
The Stroop assesses processing speed and executive
functioning, and is scored as the correct number of
words, colours and colourewords identiﬁed in 45 s on
each subtest.
Health outcomes
Three health outcome measuresdHRQoL, depressive
symptoms and sense of controldare included. Each has
established reliability and validity, and yet is relatively
brief. The 36-item SF-36
44 is used to measure HRQoL.
Scores on each of its eight subscales are transformed to
range from 0 (worst health) to 100 (best health).
Depressive symptoms are measured using the 12-item
Center for Epidemiologic Studies Depression scale
(CESD-12).
45 CESD-12 scores range from 0 (no symp-
toms acknowledged) to 36 (all 12 symptoms acknowl-
edged to occur most or all of the time), with scores $9
being the screening threshold for suspected clinical
depression.
34 Sense of control is measured using
Mirowsky and Ross’ eight-item 232 Index.
46 The sense
of control score is the sum of the item responses and
ranges from maximally denying ( 16) to maximally
claiming control (+16).
Covariates
To adjust for potential heterogeneity across the treat-
ment groups, several covariates were obtained at
randomisation. These included various sociodemo-
graphic characteristics, multiple indicators of socio-
economic status, medical history, ADLs and IADLs,
perceived stress, self-efﬁcacy and, attitudes towards and
the use of computers in everyday life, among others.
Road Tour training programme
In November 2007, Posit Science Corporation (San
Francisco, California) acquired the rights to Ball and
Roenker’s original visual speed-of-processing training
programme.
19 20 26 While Posit Science retained all of
the original tasks, it modiﬁed the delivery platform to be
user-friendly and self-administered, improving the ease
of dissemination and implementation. The addition of
certain game elements also improves user engagement
and enhances compliance. The resulting second-gener-
ation computerised speed of processing training
programme is known as Road Tour and is commercially
available (http://www.positscience.com/our-products).
Road Tour’s appearance is shown in ﬁgure 2. After
clicking on the start button to initiate training, ﬁgure 2B
is shown. Here, both the licence plate area and the eight
circular locations in the near orbit surrounding it are
empty. The empty licence plate is then replaced, as in
ﬁgure 2C, with the target vehicle, either a car or a truck.
Similarly, the eight empty circular locations surrounding
the licence plate are then replaced with seven distracter
stimuli (rabbit crossing signs) or the target sign (Route
66). The stimuli (car vs truck and rabbit crossing vs
Route 66 sign) are presented for a speciﬁed time and are
then replaced by ﬁgure 2D. The amount of time that
ﬁgure 2C remains on the screen before being replaced
by ﬁgure 2D is measured in milliseconds. In ﬁgure 2E,
both target vehicles (the car and truck) are presented in
the centre of the screen. The user ﬁrst clicks on the
correct target vehicle (car or truck) and then on the
circular location where the correct peripheral target
(Route 66 sign) appeared (ﬁgure 2F). The goal is to
improve cognitive processing speed by progressively
reducing the milliseconds of exposure that ﬁgure 2C
remains on the screen with subsequent correct identiﬁ-
cation of both the stimuli (car or truck) and target
(Route 66) sign.
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pant’s performance such that it maintains a 75% success
rate before advancing to a shorter exposure time. The
gaming aspect involves the user deciding where to place
a car in the ring of cars when a trial (identiﬁcation of the
vehicle and Route 66 sign) is correct (ﬁgure 2F). When
car placement produces a sequence of three cars of the
same colour, these cars disappear, and the user’s car
moves around the ring. This gaming element increases
the user’s engagement in the exercise. Each lap around
the ring gets the user’s car closer to the next destination.
In the initial (early) trials of the exercise, there are only
seven distracters within the near orbit around the licence
plate. As the user progresses, three changes occur to
increase task difﬁculty: (a) the target visual ﬁeld expands
(ﬁgure 3AeC) by progressing outward from the licence
plate to add medium and distal orbits; (b) these are
accompanied by an increasing number of distracters to
populate all three orbits (up to 47; ﬁgure 4A,B); and (c)
the vehicle pairs morph through nine different stages or
pairs to become more similar and thus more difﬁcult to
differentiate (ﬁgure 5).
Road Tour captures the participant’s experience in two
ways, both of which are routinely sent in the background
to Posit Science and our research laboratory over the
internet using secure ﬁle encryption protocols. One
assessment is the amount of time spent playing Road
Tour. The targeted standard training dose was 10 h. Use
can also be assessed by the percentage of completion of
all 81 of the available exercise sets. In addition to
monitoring use, Road Tour also administers an assess-
ment of visual-processing speed at random intervals.
This assessment is the number of milliseconds that
ﬁgure 2C must remain exposed to the participant to
achieve the speciﬁed correct identiﬁcation (success)
rate. It is estimated as the log mean of two randomly
interleaved zippy estimation by sequential testing
47
adaptive Bayesian algorithms
48 which employ a cumula-
tive Gaussian curve starting at 6.75% (chance correct
rate) and ending at 95% (100% minus 5% lapse rate)
with the threshold set at 50%.
Group 1
Immediately after completing their informed consent
and baseline interviews, participants randomly assigned
to Group 1 (on-site Road Tour training without
boosters) were scheduled for their ﬁrst 2 h session in
our laboratory, which includes two identical training
rooms conﬁgured with ﬁve private PC workstation
areas. The Road Tour training software is on the PCs in
one training room, and the computerised crossword
puzzle software is on the PCs in the other. At their ﬁrst
session, Group 1 participants were assigned their study-
s p e c i ﬁ cI Dn u m b e ra n d ,a f t e rr e c e i v i n ga b o u t
5e10 min of scripted instruction on how to use Road
Tour, were asked to use the training programme for the
r e m a i n d e ro ft h a ts e s s i o n .P a r t i c i p a n t sw e r et h e n
scheduled for their next 2 h training session, which
usually occurred the following week. A total of ﬁve,
weekly 2 h training sessions were scheduled for the
standard training dose. After completing 10 h of
training, or by 6e8 weeks postrandomisation, which-
ever came ﬁrst, Group 1 participants were invited back
to the laboratory for their post-training assessments
using the UFOV test.
Group 2
Participants randomly assigned to Group 2 (on-site Road
Tour training with boosters) were treated the same as
Figure 2 The initial Road Tour sequence
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participants, Group 2 participants were invited back to
our laboratory for two 2 h booster training sessions at
11 months postrandomisation. Group 2 participants also
completed additional UFOV testing both before and
after their booster training.
Group 3
Participants randomised to Group 3 (on-site compu-
terised crossword puzzle training; attention control)
were treated the same as participants randomised to
Group 1, with one exception. Instead of using Road Tour,
Group 3 participants were taken to our second training
room and instructed on how to use the computerised
crossword puzzle programme (Boatload of Crosswords,
Boatload Puzzles, LLC, Yorktown Heights, New York).
Group 4
Participants randomly assigned to Group 4 (at-home
Road Tour training) were scheduled for their ﬁrst session
in our laboratory immediately after completing their
informed consent and baseline interviews. They,
however, were taken to a third room in which they were
assigned their study-speciﬁc ID number and were then
shown (step by step) how to load the software on a PC.
After this, they received about 5e10 min of scripted
instruction on how to use Road Tour and then practised
using it for about 10e15 min. Group 4 participants were
then sent home with the CD containing the Road Tour
software to load on their home PCs, as well as a detailed
set of step-by-step instructions containing all of the
screenshots that they would encounter in doing so. They
were also given the phone number and email informa-
tion for contacting the Project Coordinator (MMD) to
answer any questions they might have about loading the
software onto their home PCs. Group 4 participants were
asked to use Road Tour at home for 10 h or more during
the next 5e6 weeks. At 6e8 weeks postrandomisation,
Group 4 participants were invited back to the laboratory
for their post-training assessments using the UFOV test.
At that time, they were reminded that they could
continue using Road Tour as often as they liked.
Analysis
For the purposes of statistical modelling, we deﬁne three
mutually exclusive 1e0 binary indicators G1, G2 and G4
to indicate whether the participant is in the on-site speed
of processing intervention without boosters, the on-site
speed of processing intervention with boosters, or the at-
home speed of processing group. The on-site crossword
puzzle (attention control; G3) group participant will
have all three of these indicators set to zero. Other
covariates are contained in the vector X. For continuous
outcomes such as visual processing speed we will use
multiple linear regression models
49 that may be
expressed in their simplest form as:
Y12 ¼ b0 þ b1Yb þ b2G1 þ b3G2 þ b4G4 þ b5X þ 3
where Y12 is the dependent variable at the 12-month
postrandomisation assessment, bo is the intercept, b1 is
the coefﬁcient for Yb (the baseline (randomisation) value
of the dependent variable), b2 is the coefﬁcient for G1
(Group 1), b3 is the coefﬁcient for G2 (Group 2), b4 is the
coefﬁcient for G4 (Group 4), b5 is the vector of
Figure 3 Expansion of the target visual ﬁeld
Figure 4 Increasing the number
of visual distractors
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error term. The effect of b1 represents a stability coefﬁ-
cient; the effects of b2, b3 and b4 represent the effects of
being randomised to the three Road Tour intervention
groups (Groups 1, 2 and 4), respectively, on changes in
the dependent variable compared with those observed for
the attention control group (Group 3); and the effects of
b5 represent the effects of the covariates on changes in
the dependent variable. When the dependent variable is
a count measure, we will use Poisson or negative binomial
regression techniques, and for binary outcomes (such as
the onset of suspected clinical depression (CESD-12
scores $9)), we will use logistic regression.
Modiﬁcations to the original protocol
The protocol entry for IHAMS that was originally
submitted to http://www.ClinicalTrials.gov was subse-
quently modiﬁed to reﬂect two changes. First, our orig-
inal power calculations in the USA NIH Challenge Grant
Application were based on a meta-analysis of previously
published studies using Ball and Roenker’s intervention.
Once IHAMS was funded, we used original data from the
ACTIVE baseline and 1-year follow-up interviews to
estimate statistical power and sample size requirements
more accurately. Those analyses indicated that a total of
600 participants across the four study groups would yield
at least 80% power to detect an effect size 0.25 at a¼0.05
with a two-sided test. Therefore, we changed the sample
size goals from 900 to 600, and ultimately enrolled and
randomised 681 participants. Second, all six neuro-
psychological tests were originally listed in the protocol
as primary outcomes. Because only the UFOV was used
in ACTIVE, however, we could only power the study
based on it. Therefore, the ﬁve other neuropsychological
tests were changed to secondary outcomes.
ETHICS AND DISSEMINATION
IHAMS was viewed as a minimal risk trial by the
University of Iowa IRB for three reasons. First, no
adverse effects were reported from the earlier version
that was used in ACTIVE. Second, Boatload of Crosswords,
the computerised crossword puzzle program, is the most
popular puzzle game commercially available. Third, our
IRB protocol (200908789) established procedures to
ensure that participation was voluntary, that participants
could quit at any time they chose, that signed informed
consent was obtained, that conﬁdentiality was main-
tained and that data security was rigorous. Participants
received $25 for completing their randomisation inter-
views, $5 for each UFOV test and $50 for completing the
1-year postrandomisation interview.
We will disseminate the results from IHAMS via
conference presentations and journal publications. Four
subsequent journal articles will focus on (1) the post-
training UFOV results, (2) the 1-year postrandomisation
results on all six neuropsychological assessments, (3) the
health outcome results at 1-year postrandomisation and
(4) effectiveness-derived doseeresponse curves. If the
1-year postrandomisation results demonstrate the efﬁ-
cacy and effectiveness of Road Tour, Posit Science will
work with government agencies to make the programme
available for wide-scale implementation ‘at only a frac-
tion of the current per-user cost.’
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